Global Blood Diseases

• Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026

  Feb 08, 2022  |  Published by: MarketsandMarkets  |  USD 4,950

  ... global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6% during the forecast period. Market growth is driven by factors such ... Read More

• Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery Including: 1) By Type: Hemophilia; Blood Products; Anemia and Other Blood Disorder Drugs 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others 3) By Route Of Administration: Oral; Parenteral 4) By Drug Classification: Branded Drugs; Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs Covering: Takeda Pharmaceutical Company; Roche Holding AG; Amgen Inc.; Novartis AG; Novo Nordisk A/S; Daiichi Sankyo Company

  Feb 01, 2022  |  Published by: The Business Research Company  |  USD 5,000

  ... hematology drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 48+ geographies. Understand how the ... Read More

• Global Sickle Cell Disease Treatment Market 2021-2025

  Jan 18, 2022  |  Published by: TechNavio  |  USD 2,500

  ... during the forecast period. Our report on the sickle cell disease treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. ... Read More

< prev 3 4 5 6 7 8 next >